<DOC>
	<DOCNO>NCT01788722</DOCNO>
	<brief_summary>The objective study investigate collect post marketing data safety efficacy Visanne follow-up visit 6 month treatment - subset patient - optional long-term follow-up visit 1 year treatment daily practice treatment condition Korean woman obtain data drug utilization treatment endometriosis .</brief_summary>
	<brief_title>Regulatory Post Marketing Surveillance Study Korea</brief_title>
	<detailed_description />
	<mesh_term>Endometriosis</mesh_term>
	<mesh_term>Dienogest</mesh_term>
	<criteria>Signed date informed consent Women diagnose physician endometriosis Women prescribe Visanne ( dienogest 2mg ) first time study period All contraindication accord local marketing authorization consider .</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>